ArticlePigment cell & melanoma research2023

Neutrophil-to-eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti-PD-1 therapy.

Vincent Pozorski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.